|
1
|
Estey EH: Acute myeloid leukemia: 2013
update on risk-stratification and management. Am J Hematol.
88:318–327. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Davis AS, Viera AJ and Mead MD: Leukemia:
An overview for primary care. Am Fam Physician. 89:731–738.
2014.PubMed/NCBI
|
|
3
|
Yi S, Wen L, He J, Wang Y, Zhao F, Zhao J,
Zhao Z, Cui G and Chen Y: Deguelin, a selective silencer of the
NPM1 mutant, potentiates apoptosis and induces differentiation in
AML cells carrying the NPM1 mutation. Ann Hematol. 94:201–210.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fang F and Zhu P: Analysis of gene
expression profiles to improve the treatment of leukemia. Zhongguo
Shi Yan Xue Ye Xue Za Zhi. 22:1735–1738. 2014.(In Chinese).
PubMed/NCBI
|
|
5
|
Schlenk RF and Döhner H: Genomic
applications in the clinic: Use in treatment paradigm of acute
myeloid leukemia. Hematology Am Soc Hematol Educ Program.
2013:324–330. 2013.PubMed/NCBI
|
|
6
|
Pogribny IP, Pogribna M, Christman JK and
James SJ: Single-site methylation within the p53 promoter region
reduces gene expression in a reporter gene construct: Possible in
vivo relevance during tumorigenesis. Cancer Res. 60:588–594.
2000.PubMed/NCBI
|
|
7
|
Ushijima T, Watanabe N, Okochi E, Kaneda
A, Sugimura T and Miyamoto K: Fidelity of the methylation pattern
and its variation in the genome. Genome Res. 13:868–874. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Itzykson R, Thépot S, Berthon C, Delaunay
J, Bouscary D, Cluzeau T, Turlure P, Prébet T, Dartigeas C,
Marolleau JP, et al: Azacitidine for the treatment of relapsed and
refractory AML in older patients. Leuk Res. 39:124–130. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tao YF, Xu LX, Lu J, Cao L, Li ZH, Hu SY,
Wang NN, Du XJ, Sun LC, Zhao WL, et al: Metallothionein III (MT3)
is a putative tumor suppressor gene that is frequently inactivated
in pediatric acute myeloid leukemia by promoter hypermethylation. J
Transl Med. 12:1822014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kawagoe H, Kandilci A, Kranenburg TA and
Grosveld GC: Overexpression of N-Myc rapidly causes acute myeloid
leukemia in mice. Cancer Res. 67:10677–10685. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bennett JM, Catovsky D, Daniel MT,
Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposed revised
criteria for the classification of acute myeloid leukemia. A report
of the French-American-British Cooperative Group. Ann Intern Med.
103:620–625. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fasan A, Alpermann T, Haferlach C,
Grossmann V, Roller A, Kohlmann A, Eder C, Kern W, Haferlach T and
Schnittger S: Frequency and prognostic impact of CEBPA proximal,
distal and core promoter methylation in normal karyotype AML: A
study on 623 cases. PLoS One. 8:e543652013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hong Q, Chen X, Ye H, Zhou A, Gao Y, Jiang
D, Wu X, Tian B, Chen Y, Wang M, et al: Association between the
methylation status of the MGMT promoter in bone marrow specimens
and chemotherapy outcomes of patients with acute myeloid leukemia.
Oncol Lett. 11:2851–2856. 2016.PubMed/NCBI
|
|
15
|
Huang Y, Ye H, Hong Q, Xu X, Jiang D, Xu
L, Dai D, Sun J, Gao X and Duan S: Association of CDKN2BAS
polymorphism rs4977574 with coronary heart disease: A case-control
study and a meta-analysis. Int J Mol Sci. 15:17478–17492. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng C, Lingyan W, Yi H, Cheng Z, Huadan
Y, Xuting X, Leiting X, Meng Y and Shiwei D: Association between
TLR2, MTR, MTRR, XPC, TP73, TP53 genetic polymorphisms and gastric
cancer: A meta-analysis. Clin Res Hepatol Gastroenterol.
38:346–359. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang L, Ye H, Hong Q, Wang L, Wang Q, Wang
H, Xu L, Bu S, Zhang L, Cheng J, et al: Elevated CpG island
methylation of GCK gene predicts the risk of type 2 diabetes in
Chinese males. Gene. 547:329–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang X, Han H, De Carvalho DD, Lay FD,
Jones PA and Liang G: Gene body methylation can alter gene
expression and is a therapeutic target in cancer. Cancer Cell.
26:577–590. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Grimwade D, Walker H, Oliver F, Wheatley
K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A and
Goldstone A: The importance of diagnostic cytogenetics on outcome
in AML: Analysis of 1,612 patients entered into the MRC AML 10
trial. The medical research council adult and Children's Leukaemia
working parties. Blood. 92:2322–2333. 1998.PubMed/NCBI
|
|
20
|
Cheng CK, Li L, Cheng SH, Ng K, Chan NP,
Ip RK, Wong RS, Shing MM, Li CK and Ng MH: Secreted-frizzled
related protein 1 is a transcriptional repression target of the
t(8;21) fusion protein in acute myeloid leukemia. Blood.
118:6638–6648. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Byun JM, Kim YJ, Yoon HJ, Kim SY, Kim HJ,
Yoon J, Min YH, Cheong JW, Park J, Lee JH, et al: Cytogenetic
profiles of 2806 patients with acute myeloid leukemia-a
retrospective multicenter nationwide study. Ann Hematol.
95:1223–1232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nucifora G, Larson RA and Rowley JD:
Persistence of the 8;21 translocation in patients with acute
myeloid leukemia type M2 in long-term remission. Blood. 82:712–715.
1993.PubMed/NCBI
|
|
23
|
Shi HX, Jiang B, Qiu JY, Lu XJ, Fu JF,
Wang DB and Lu DP: Studies of treatment strategy and prognosis on
acute myeloid leukemia with chromosome 8 and 21 translocation.
Zhonghua Xue Ye Xue Za Zhi. 26:481–484. 2005.(In Chinese).
PubMed/NCBI
|
|
24
|
Hong Q, Ye H, Tang L, Jiang D, Ji H, Dai
D, Ouyang G and Duan S: Progress in DNA Methylation Research on
Genes Associated with Acute Myeloid Leukemia. Chinese J Cell Biol.
37:299–308. 2015.
|
|
25
|
Servitzoglou M, Grenzelia M, Baka M,
Harisi M, Pourtsidis A, Bouhoutsou D, Varvoutsi M, Doganis D, Dana
H, Divane A and Kosmidis H: A novel karyotype in acute myeloid
leukemia with basophilia. Pediatr Hematol Oncol. 31:149–156. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ho PA, Kutny MA, Alonzo TA, Gerbing RB,
Joaquin J, Raimondi SC, Gamis AS and Meshinchi S: Leukemic
mutations in the methylation-associated genes DNMT3A and IDH2 are
rare events in pediatric AML: A report from the Children's oncology
group. Pediatr Blood Cancer. 57:204–209. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma JC, Qian J, Lin J, et al: Aberrant
hypomethylation of SALL4 gene is associated with intermediate and
poor karyotypes in acute myeloid leukemia. Clin Biochem.
46:304–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chim CS, Wong AS and Kwong YL: Epigenetic
inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
Ann Hematol. 82:738–742. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alvarez S, Suela J, Valencia A, et al: DNA
methylation profiles and their relationship with cytogenetic status
in adult acute myeloid leukemia. PLoS One. 5:e121972010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shah A, Andersson TM, Rachet B, Björkholm
M and Lambert PC: Survival and cure of acute myeloid leukaemia in
England, 1971–2006: A population-based study. Br J Haematol.
162:509–516. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dores GM, Devesa SS, Curtis RE, Linet MS
and Morton LM: Acute leukemia incidence and patient survival among
children and adults in the United States, 2001–2007. Blood.
119:34–43. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bhayat F, Das-Gupta E, Smith C, McKeever T
and Hubbard R: The incidence of and mortality from leukaemias in
the UK: A general population-based study. BMC Cancer. 9:2522009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Australian Institute of Health and
Welfare: Cancer survival and prevalence in Australia: Period
estimates from 1982 to 2010. Asia Pac J Clin Oncol. 9:29–39.
2013.PubMed/NCBI
|
|
34
|
Yi HG, Lee MH, Kim CS, Hong J, Park J, Lee
JH, Han BR, Kim HY, Zang DY, Kim SH, et al: Clinical
characteristics and treatment outcome of acute myeloid leukemia in
elderly patients in Korea: a retrospective analysis. Blood Res.
49:95–99. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thein MS, Ershler WB, Jemal A, Yates JW
and Baer MR: Outcome of older patients with acute myeloid leukemia:
An analysis of SEER data over 3 decades. Cancer. 119:2720–2727.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gritsaev SV, Martynkevich IS, Ziuzgin IS,
Kariagina EV, Martynenko LS, Petrova EV, Tsybakova Nlu, Ivanova MP,
Kostroma II, Tiranova SA, et al: Heterogeneity of acute myeloid
leukemia with the translocation t(8;21)(q22;q22). Ter Arkh.
86:45–52. 2014.(In Russian). PubMed/NCBI
|
